Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124071652 | 12407165 | 2 | F | 20160831 | 20160526 | 20160907 | PER | US-PFIZER INC-2016243551 | PFIZER | 74.00 | YR | F | Y | 59.00000 | KG | 20160907 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124071652 | 12407165 | 1 | PS | SKELAXIN | METAXALONE | 1 | Oral | 800 MG, 3X/DAY | U | 109637 | 13217 | 800 | MG | TABLET | TID | ||||
| 124071652 | 12407165 | 2 | SS | SKELAXIN | METAXALONE | 1 | U | 13217 | TABLET | ||||||||||
| 124071652 | 12407165 | 3 | SS | SKELAXIN | METAXALONE | 1 | U | 13217 | TABLET | ||||||||||
| 124071652 | 12407165 | 4 | SS | SKELAXIN | METAXALONE | 1 | U | 13217 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124071652 | 12407165 | 1 | Pain |
| 124071652 | 12407165 | 2 | Osteoarthritis |
| 124071652 | 12407165 | 3 | Osteoporosis |
| 124071652 | 12407165 | 4 | Fibromyalgia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124071652 | 12407165 | Drug effect incomplete | |
| 124071652 | 12407165 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |